BioNxt Solutions Inc. (OTCMKTS:BNXTF – Get Free Report) shares traded down 10% during trading on Friday . The company traded as low as $0.15 and last traded at $0.15. 100 shares were traded during trading, a decline of 93% from the average session volume of 1,362 shares. The stock had previously closed at $0.16.
BioNxt Solutions Price Performance
The stock has a market capitalization of $16.60 million, a price-to-earnings ratio of -2.94 and a beta of 0.86. The company has a 50-day simple moving average of $0.20 and a two-hundred day simple moving average of $0.29.
BioNxt Solutions (OTCMKTS:BNXTF – Get Free Report) last posted its earnings results on Wednesday, May 29th. The company reported ($0.01) EPS for the quarter.
About BioNxt Solutions
BioNxt Solutions Inc engages in generation drug formulations and delivery system in Korea, Austria, Germany, and Switzerland. The company provides drug delivery methods, such as transdermal patches and oral dissolvable films designed for delivery of neurological medications. It offers point-of-care diagnostic, including covid-19 PCR diagnostic kit, a covid rapid test; peri-implantitis Oral Biosensor, allows early detection of infection associated with dental implants; and H1N1 (Swine Flu) and H5N1 (Avian Flu) oral biosensors for early detection of highly pathogenic influenza a strains.
Recommended Stories
- Five stocks we like better than BioNxt Solutions
- Stock Dividend Cuts Happen Are You Ready?
- The Solar Stock Battle: Is Daqo or JinkoSolar Your Next Big Win?
- 3 Warren Buffett Stocks to Buy Now
- Are These Chinese Stocks a Buy? Michael Burry’s Top Picks Say Yes
- P/E Ratio Calculation: How to Assess Stocks
- Five Below Stock Faces Challenges Despite Strong Revenue Growth
Receive News & Ratings for BioNxt Solutions Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BioNxt Solutions and related companies with MarketBeat.com's FREE daily email newsletter.
